Higher stress and symptom severity are associated with worse depressive symptom profiles in patients receiving chemotherapy
- PMID: 35397404
- PMCID: PMC10788966
- DOI: 10.1016/j.ejon.2021.102031
Higher stress and symptom severity are associated with worse depressive symptom profiles in patients receiving chemotherapy
Abstract
Purpose: In a sample of oncology patients, identify subgroups of patients with distinct depressive symptom profiles and evaluate for differences in demographic and clinical characteristics, levels of stress and resilience, and the severity of common co-occurring symptoms.
Methods: Patients (n = 1327) had a diagnosis of breast, gastrointestinal, gynecological, or lung cancer; had received chemotherapy within the preceding four weeks; and were scheduled to receive at least two additional cycles of chemotherapy. Demographic and clinical characteristics, stress, resilience, and co-occurring symptoms were evaluated at enrollment. Depressive symptoms were evaluated using the Center for Epidemiological Studies-Depression (CES-D) scale a total of six times over two cycles of chemotherapy. Latent profile analysis (LPA) was used to identify subgroups of patients (i.e., latent classes) with distinct depressive symptom profiles using the six CES-D scores.
Results: Based on the findings from the LPA, 47.3% of the patients were classified as "None"; 33.6% as "Subsyndromal"; 13.8% as "Moderate"; and 5.3% as "High". Compared to None class, patients in the Subsyndromal, Moderate, and High classes had a lower functional status, a higher comorbidity burden, and a self-reported diagnosis of depression or back pain. Those patients with higher levels of depressive symptoms reported higher levels of stress, lower levels of resilience, and increased severity of co-occurring symptoms.
Conclusions: Inter-individual variability in depressive symptoms was associated with demographic and clinical characteristics, multiple types of stress and levels of resilience, as well as with the increased severity of multiple co-occurring symptoms. The risk factors associated with worse depressive symptom profiles can assist clinicians to identify high risk patients and initiate more timely supportive care interventions.
Keywords: Cancer; Depression; Distress; Latent profile analysis; Resilience; Stress.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Worst Pain Severity Profiles of Oncology Patients Are Associated With Significant Stress and Multiple Co-Occurring Symptoms.J Pain. 2022 Jan;23(1):74-88. doi: 10.1016/j.jpain.2021.07.001. Epub 2021 Jul 21. J Pain. 2022. PMID: 34298161 Free PMC article.
-
Anxiety profiles are associated with stress, resilience and symptom severity in outpatients receiving chemotherapy.Support Care Cancer. 2021 Dec;29(12):7825-7836. doi: 10.1007/s00520-021-06372-w. Epub 2021 Jun 26. Support Care Cancer. 2021. PMID: 34176016 Free PMC article.
-
Identification of subgroups of chemotherapy patients with distinct sleep disturbance profiles and associated co-occurring symptoms.Sleep. 2019 Oct 9;42(10):zsz151. doi: 10.1093/sleep/zsz151. Sleep. 2019. PMID: 31361899 Free PMC article.
-
Telephone interventions for symptom management in adults with cancer.Cochrane Database Syst Rev. 2020 Jun 2;6(6):CD007568. doi: 10.1002/14651858.CD007568.pub2. Cochrane Database Syst Rev. 2020. PMID: 32483832 Free PMC article.
-
Distinct Wound Healing and Quality-of-Life Outcomes in Subgroups of Patients With Venous Leg Ulcers With Different Symptom Cluster Experiences.J Pain Symptom Manage. 2017 May;53(5):871-879. doi: 10.1016/j.jpainsymman.2016.12.336. Epub 2017 Jan 4. J Pain Symptom Manage. 2017. PMID: 28063868 Review.
Cited by
-
Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients.J Psychosoc Oncol. 2024;42(6):769-792. doi: 10.1080/07347332.2024.2326146. Epub 2024 Mar 25. J Psychosoc Oncol. 2024. PMID: 38528755 Free PMC article.
-
Chemotherapy-related symptom networks in distinct subgroups of Chinese patients with gastric cancer.Asia Pac J Oncol Nurs. 2023 Dec 27;11(3):100366. doi: 10.1016/j.apjon.2023.100366. eCollection 2024 Mar. Asia Pac J Oncol Nurs. 2023. PMID: 38362311 Free PMC article.
References
-
- Akechi T, Nakano T, Akizuki N, Okamura M, Sakuma K, Nakanishi T, Yoshikawa E, Uchitomi Y, 2003. Somatic symptoms for diagnosing major depression in cancer patients. Psychosomatics 44, 244–248. - PubMed
-
- Bergerot CD, Mitchell H-R, Ashing KT, Kim Y, 2017. A prospective study of changes in anxiety, depression, and problems in living during chemotherapy treatments: effects of age and gender. Support Care Cancer 25, 1897–1904. - PubMed
-
- Bohn MJ, Babor TF, Kranzler HR, 1995. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol 56, 423–432. - PubMed
-
- Butler SS, Turner W, Kaye LW, Ruffin L, Downey R, 2005. Depression and caregiver burden among rural elder caregivers. J Gerontol Soc Work 46, 47–63. - PubMed